Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-064782
Filing Date
2013-11-29
Accepted
2013-11-29 09:00:13
Documents
3
Period of Report
2013-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v361753_6k.htm 6-K 1137811
2 GRAPHIC tlogo.jpg GRAPHIC 9050
3 GRAPHIC tlogo1.jpg GRAPHIC 4296
  Complete submission text file 0001144204-13-064782.txt   1157483
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 131249247
SIC: 2834 Pharmaceutical Preparations